Annual EBITDA:
-$63.98M+$34.35M(+34.93%)Summary
- As of today, MIRM annual EBITDA is -$63.98 million, with the most recent change of +$34.35 million (+34.93%) on December 31, 2024.
- During the last 3 years, MIRM annual EBITDA has risen by +$108.46 million (+62.90%).
- MIRM annual EBITDA is now -2094.00% below its all-time high of -$2.92 million, reached on December 31, 2018.
Performance
MIRM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$4.19M+$8.19M(+204.65%)Summary
- As of today, MIRM quarterly EBITDA is $4.19 million, with the most recent change of +$8.19 million (+204.65%) on June 30, 2025.
- Over the past year, MIRM quarterly EBITDA has increased by +$18.77 million (+128.71%).
- MIRM quarterly EBITDA is now -93.18% below its all-time high of $61.38 million, reached on December 31, 2021.
Performance
MIRM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$18.79M+$18.77M(+49.97%)Summary
- As of today, MIRM TTM EBITDA is -$18.79 million, with the most recent change of +$18.77 million (+49.97%) on June 30, 2025.
- Over the past year, MIRM TTM EBITDA has increased by +$54.68 million (+74.42%).
- MIRM TTM EBITDA is now -28810.77% below its all-time high of -$65.00 thousand, reached on September 30, 2018.
Performance
MIRM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MIRM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +34.9% | +128.7% | +74.4% |
| 3Y3 Years | +62.9% | +114.4% | +54.6% |
| 5Y5 Years | -17.6% | +118.1% | +77.1% |
MIRM EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +62.9% | at high | +106.1% | at high | +87.8% |
| 5Y | 5-Year | -17.6% | +62.9% | -93.2% | +106.1% | at high | +88.5% |
| All-Time | All-Time | -2094.0% | +62.9% | -93.2% | +106.1% | >-9999.0% | +88.5% |
MIRM EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $4.19M(+204.7%) | -$18.79M(+50.0%) |
| Mar 2025 | - | -$4.00M(+72.8%) | -$37.56M(+23.3%) |
| Dec 2024 | -$63.98M(+34.9%) | -$14.73M(-246.9%) | -$48.97M(+19.2%) |
| Sep 2024 | - | -$4.25M(+70.9%) | -$60.62M(+17.5%) |
| Jun 2024 | - | -$14.58M(+5.4%) | -$73.47M(+42.4%) |
| Mar 2024 | - | -$15.41M(+41.6%) | -$127.55M(+6.5%) |
| Dec 2023 | -$98.33M(+22.9%) | -$26.38M(-54.2%) | -$136.49M(+3.1%) |
| Sep 2023 | - | -$17.10M(+75.1%) | -$140.84M(+8.8%) |
| Jun 2023 | - | -$68.66M(-182.0%) | -$154.37M(-34.4%) |
| Mar 2023 | - | -$24.35M(+20.8%) | -$114.83M(+6.5%) |
| Dec 2022 | -$127.54M(+26.0%) | -$30.73M(-0.3%) | -$122.85M(-299.6%) |
| Sep 2022 | - | -$30.63M(-5.2%) | -$30.74M(+25.7%) |
| Jun 2022 | - | -$29.12M(+10.1%) | -$41.37M(+19.2%) |
| Mar 2022 | - | -$32.38M(-152.7%) | -$51.18M(+22.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$172.44M(-66.3%) | $61.38M(+248.8%) | -$65.77M(+59.9%) |
| Sep 2021 | - | -$41.25M(-6.0%) | -$163.85M(-13.8%) |
| Jun 2021 | - | -$38.93M(+17.1%) | -$143.95M(-12.4%) |
| Mar 2021 | - | -$46.96M(-28.0%) | -$128.12M(-25.2%) |
| Dec 2020 | -$103.67M(-90.5%) | -$36.70M(-71.9%) | -$102.31M(-24.9%) |
| Sep 2020 | - | -$21.35M(+7.6%) | -$81.93M(-7.3%) |
| Jun 2020 | - | -$23.10M(-9.2%) | -$76.36M(-13.6%) |
| Mar 2020 | - | -$21.15M(-29.5%) | -$67.20M(-28.7%) |
| Dec 2019 | -$54.42M(-1766.2%) | -$16.33M(-3.5%) | -$52.21M(-45.5%) |
| Sep 2019 | - | -$15.78M(-13.1%) | -$35.88M(-77.9%) |
| Jun 2019 | - | -$13.95M(-126.5%) | -$20.17M(-224.1%) |
| Mar 2019 | - | -$6.16M(-9372.3%) | -$6.22M(-9472.3%) |
| Dec 2018 | -$2.92M | - | - |
| Sep 2018 | - | -$65.00K | -$65.00K |
FAQ
- What is Mirum Pharmaceuticals, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Mirum Pharmaceuticals, Inc.?
- What is Mirum Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Mirum Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Mirum Pharmaceuticals, Inc.?
- What is Mirum Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Mirum Pharmaceuticals, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Mirum Pharmaceuticals, Inc.?
- What is Mirum Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Mirum Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of MIRM is -$63.98M
What is the all-time high annual EBITDA for Mirum Pharmaceuticals, Inc.?
Mirum Pharmaceuticals, Inc. all-time high annual EBITDA is -$2.92M
What is Mirum Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, MIRM annual EBITDA has changed by +$34.35M (+34.93%)
What is Mirum Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of MIRM is $4.19M
What is the all-time high quarterly EBITDA for Mirum Pharmaceuticals, Inc.?
Mirum Pharmaceuticals, Inc. all-time high quarterly EBITDA is $61.38M
What is Mirum Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, MIRM quarterly EBITDA has changed by +$18.77M (+128.71%)
What is Mirum Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of MIRM is -$18.79M
What is the all-time high TTM EBITDA for Mirum Pharmaceuticals, Inc.?
Mirum Pharmaceuticals, Inc. all-time high TTM EBITDA is -$65.00K
What is Mirum Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, MIRM TTM EBITDA has changed by +$54.68M (+74.42%)